Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1992 1
1994 1
1995 2
1997 1
1999 1
2000 1
2001 3
2002 5
2003 5
2004 4
2005 5
2006 4
2007 8
2008 13
2009 15
2010 6
2011 15
2012 10
2013 9
2014 8
2015 12
2016 24
2017 20
2018 26
2019 20
2020 23
2021 28
2022 20
2023 18
2024 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

276 results

Results by year

Filters applied: . Clear all
Page 1
Muscle Tone Physiology and Abnormalities.
Ganguly J, Kulshreshtha D, Almotiri M, Jog M. Ganguly J, et al. Among authors: jog m. Toxins (Basel). 2021 Apr 16;13(4):282. doi: 10.3390/toxins13040282. Toxins (Basel). 2021. PMID: 33923397 Free PMC article. Review.
Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease.
Nalls MA, Pankratz N, Lill CM, Do CB, Hernandez DG, Saad M, DeStefano AL, Kara E, Bras J, Sharma M, Schulte C, Keller MF, Arepalli S, Letson C, Edsall C, Stefansson H, Liu X, Pliner H, Lee JH, Cheng R; International Parkinson's Disease Genomics Consortium (IPDGC); Parkinson's Study Group (PSG) Parkinson's Research: The Organized GENetics Initiative (PROGENI); 23andMe; GenePD; NeuroGenetics Research Consortium (NGRC); Hussman Institute of Human Genomics (HIHG); Ashkenazi Jewish Dataset Investigator; Cohorts for Health and Aging Research in Genetic Epidemiology (CHARGE); North American Brain Expression Consortium (NABEC); United Kingdom Brain Expression Consortium (UKBEC); Greek Parkinson's Disease Consortium; Alzheimer Genetic Analysis Group; Ikram MA, Ioannidis JP, Hadjigeorgiou GM, Bis JC, Martinez M, Perlmutter JS, Goate A, Marder K, Fiske B, Sutherland M, Xiromerisiou G, Myers RH, Clark LN, Stefansson K, Hardy JA, Heutink P, Chen H, Wood NW, Houlden H, Payami H, Brice A, Scott WK, Gasser T, Bertram L, Eriksson N, Foroud T, Singleton AB. Nalls MA, et al. Nat Genet. 2014 Sep;46(9):989-93. doi: 10.1038/ng.3043. Epub 2014 Jul 27. Nat Genet. 2014. PMID: 25064009 Free PMC article.
Ambroxol as a novel disease-modifying treatment for Parkinson's disease dementia: protocol for a single-centre, randomized, double-blind, placebo-controlled trial.
Silveira CRA, MacKinley J, Coleman K, Li Z, Finger E, Bartha R, Morrow SA, Wells J, Borrie M, Tirona RG, Rupar CA, Zou G, Hegele RA, Mahuran D, MacDonald P, Jenkins ME, Jog M, Pasternak SH. Silveira CRA, et al. Among authors: jog m. BMC Neurol. 2019 Feb 9;19(1):20. doi: 10.1186/s12883-019-1252-3. BMC Neurol. 2019. PMID: 30738426 Free PMC article. Clinical Trial.
Minipolymyoclonus: A Critical Appraisal.
Ganguly J, Chai JR, Jog M. Ganguly J, et al. Among authors: jog m. J Mov Disord. 2021 May;14(2):114-118. doi: 10.14802/jmd.20166. Epub 2021 May 26. J Mov Disord. 2021. PMID: 34062647 Free PMC article. No abstract available.
Mercury and Movement Disorders: The Toxic Legacy Continues.
Ganguly J, Kulshreshtha D, Jog M. Ganguly J, et al. Among authors: jog m. Can J Neurol Sci. 2022 Jul;49(4):493-501. doi: 10.1017/cjn.2021.146. Epub 2021 Jun 24. Can J Neurol Sci. 2022. PMID: 34346303 Review.
Botulinum Toxin Induced Atrophy: An Uncharted Territory.
Salari M, Sharma S, Jog MS. Salari M, et al. Among authors: jog ms. Toxins (Basel). 2018 Aug 2;10(8):313. doi: 10.3390/toxins10080313. Toxins (Basel). 2018. PMID: 30072597 Free PMC article. Review.
White matter hyperintensities and smaller cortical thickness are associated with neuropsychiatric symptoms in neurodegenerative and cerebrovascular diseases.
Ozzoude M, Varriano B, Beaton D, Ramirez J, Adamo S, Holmes MF, Scott CJM, Gao F, Sunderland KM, McLaughlin P, Goubran M, Kwan D, Roberts A, Bartha R, Symons S, Tan B, Swartz RH, Abrahao A, Saposnik G, Masellis M, Lang AE, Marras C, Zinman L, Shoesmith C, Borrie M, Fischer CE, Frank A, Freedman M, Montero-Odasso M, Kumar S, Pasternak S, Strother SC, Pollock BG, Rajji TK, Seitz D, Tang-Wai DF, Turnbull J, Dowlatshahi D, Hassan A, Casaubon L, Mandzia J, Sahlas D, Breen DP, Grimes D, Jog M, Steeves TDL, Arnott SR, Black SE, Finger E, Rabin J; ONDRI Investigators; Tartaglia MC. Ozzoude M, et al. Among authors: jog m. Alzheimers Res Ther. 2023 Jun 20;15(1):114. doi: 10.1186/s13195-023-01257-y. Alzheimers Res Ther. 2023. PMID: 37340319 Free PMC article.
276 results